Washington faculty receive $250,000 grant to enhance expertise in radiation epidemiology
Dr. Parveen Bhatti and Dr. Amanda Phipps, from the University of Washington School of Public Health, have received $250,000 from the Radiation Effects Research Foundation (RERF) to support investigative and educational efforts focused on the health effects of atomic bomb radiation.
An STI that you probably don't even know about is becoming common and resistant to medications
You’ve likely never heard of, or been tested for it, but a sexually transmitted infection that’s fairly common could now be resistant to antibiotic medications. Mycoplasma genitalium, or MG, is not a new bacteria and was first identified in the 1980s. According to the Centers for Disease Control and Prevention, it is more common than gonorrhea and chlamydia, though it's not as easily recognized as the other two. Professor Lisa Manhart is quoted.
Sexually transmitted diseases were once considered rare in older adults, but that is changing. HPV researcher and associate professor of epidemiology, Rachel L. Winer is quoted.
Jesse Jones-Smith co-leads study of soda-tax impact on Seattle health, economics
How will we know if Seattle’s new soda tax, which takes effect Jan. 1, actually reduces the consumption of sugary drinks? University of Washington researchers have been tasked with finding out, under a four-year study funded by the City of Seattle. A multi-disciplinary team, led by obesity epidemiologist Jesse Jones-Smith of the UW School of Public Health and Nadine Chan of Public Health – Seattle & King County, will assess how the new tax changes buying and drinking habits over the next few years.
Washington researchers work to improve survival of hospitalized children with HIV
The benefits of initiating ART among children during hospitalization are less understood. Because these children are already very sick with a weakened immune system, they may not fully benefit from ART and have tragically high death rates once they enter the hospital. A new study conducted by researchers at the University of Washington School of Public Health seeks to understand the timing of ART treatment of these children. Dr. Irene Njuguna, a Kenyan physician and doctoral student in the UW Department of Epidemiology, is the lead author of the sutdy.
Should the U.S. look at gun violence as a public health issue?
For more than two decades, Congress has restricted the Centers for Disease Control and Prevention from funding public health research into gun violence. Dr. Fred Rivara, a professor of pediatrics and epidemiology at the University of Washington School of Medicine and a former recipient of CDC funding to study gun violence, argues that the U.S. needs to go back to looking at the issue from a public health perspective.
Washington: Genetic variants found to raise infection risk among HIV-exposed people
Researchers from the University of Washington School of Public Health have pinpointed genetic variants that markedly increase HIV infection risk among people exposed to the virus. Co-authors of this study included adjunct professor Connie Celum, and professor Jared Baeten.
Washington faculty member wins national award for leadership in maternal and child health
Dr. Daniel Enquobahrie, associate professor of epidemiology, received the 2017 Loretta P. Lacey Academic Leadership Award for excellence in teaching and leadership in maternal and child health (MCH). The award was presented by the Association of Teachers of Maternal and Child Health at an event in Atlanta on November 5.
Years Before heading offshore, herpes researcher experimented on people In U.S.
Three years before launching an offshore herpes vaccine trial, Southern Illinois University associate professor William Halford vaccinated patients in U.S. hotel rooms in brazen violation of U.S. law, a Kaiser Health News investigation has found. Professor Anna Wald, a herpes expert, shares her thoughts.
Washington faculty member leads study to identify metastatic breast cancer differences
Researchers have identified differences in tumor characteristics and survival in women diagnosed with de novo stage IV metastatic breast cancer compared to those with recurrent metastatic breast cancer, according to a study published in the journal Breast Cancer Research and Treatment. Lead author Dr. Judith Malmgren, president of HealthStat Consulting, Inc. and affiliate assistant professor of epidemiology at the University of Washington School of Public Health is quoted.